Status:
COMPLETED
Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Surgery for cancer of the esophagus is associated with a high risk of postoperative complications. It has been shown that the risk of postoperative complications can be decreased by optimising the amo...
Eligibility Criteria
Inclusion
- Patients scheduled for transthoracic esophageal resection because of malignancy, without colonic interposition who leave informed consent
Exclusion
- ASA 4 or 5
- Atrial Fibrillation
- Significant Aortic or Mitral Valve Insufficiency
- Preoperative planned extensive monitoring beyond CVP, arterial blood pressure, diuresis, ECG and other standard monitors
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01416077
Start Date
October 1 2011
End Date
October 1 2015
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Linkoeping
Linköping, Sweden, 58246